Merck Antitrust Scheme Frustrated by … Merck, UK Regulators Say

Drug Industry Daily
A A
Merck may not have broken any antitrust laws with a discount scheme for its rheumatoid arthritis drug Remicade—but not for lack of trying, British regulators concluded.

To View This Article:

Login

Subscribe To Drug Industry Daily